The launch of Climate Performance Solutions marks the expansion of Vizient’s portfolio of impact spend services to help providers and suppliers achieve their environmental, social and governance goals.
The agreement includes access to Vizient’s industry-leading contract portfolio of medical devices, supplies and pharmaceuticals as well as analytics-enabled solutions to drive operational and clinical efficiencies.
The planned acquisition brings together two of the industry’s most trusted advisors to help healthcare organizations deliver high-quality patient care to their communities.
The report shows progress on Vizient’s environmental, social and governance performance as well as support for sustainability efforts in the healthcare industry.
Vizient, Inc. showcased the Vizient Vulnerability Index™ at the Healthcare Innovation Expo on Capitol Hill, an event hosted by the Healthcare Leadership Council in collaboration with the Health Care Innovation Caucus.
Vizient, Inc. offered comments to the Centers for Medicare and Medicaid Services on the FY 2025 Inpatient Prospective Payment System (IPPS) Proposed Rule.
Sg2, a Vizient, Inc. company, released its 2024 Impact of Change®, projecting continued constraints on patient access to emergency department (ED) and inpatient (IP) care.
The agreement for the Ohio-based healthcare provider will maximize cost savings and supply chain efficiencies through Vizient spend management services
Today, Vizient, Inc. submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to its Request for Information (RFI) on Medicare Advantage (MA) data.
While the prevalence of behavioral health conditions was roughly the same in both groups, treatment and emergency department visits among patients in each group varied.
The briefing, attended by a standing-room only crowd, focused on the disruptions caused by Medicare Advantage organizations and how hospitals are navigating the myriad challenges to provide timely and seamless care to MA beneficiaries.
The collaboration elevates NRP’s support of newly licensed nurses transitioning from classroom to clinical practice to promote quality and safety and reduce turnover
The inaugural symposium brought together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals to discuss the promise the rapidly expanding market of cell, gene and other advanced therapies.
This is Vizient’s third time being named to this prestigious list. Earning a spot means that Vizient is one of the best companies to work for in the country.
The recommendations focus on appropriate communication, secure access, management of critically ill patients who are unable to run, hide and fight, and include tactics for addressing post-event trauma.